MTD-220

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameMTD-220
Drug Alias NameMonoclonal antibody (Biodexa Pharmaceuticals)Monoclonal antibody (Midatech Pharma)MTD-220
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/Indications +[1N/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBiodexa Pharmaceuticals PLC
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBiodexa Pharmaceuticals PLC
Active IndicationsN/A
Inactive Indications +[1N/A

Other Information

ATC CodeN/A
Related LinksN/A